SLDB Solid Biosciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SLDB

Price (delayed)

$8.02

Market cap

$859.95M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.91

Enterprise value

$720.07M

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 72
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 4
Highlights
SLDB's quick ratio is up by 47% year-on-year and by 5% since the previous quarter
The equity is up by 45% year-on-year
The net income fell by 34% YoY and by 8% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://www.solidbio.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of SLDB

SLDB stock price

How has the Solid Biosciences stock price performed over time
Intraday
-10.09%
1 week
-8.03%
1 month
-13.76%
1 year
50.47%
YTD
42.2%
QTD
-19.72%

Financial performance

How have Solid Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$212.15M
Net income
-$207.1M
Gross margin
N/A
Net margin
N/A
The operating income has declined by 35% year-on-year and by 8% since the previous quarter
The net income fell by 34% YoY and by 8% QoQ

Price vs fundamentals

How does SLDB's price correlate with its fundamentals

Growth

What is Solid Biosciences's growth rate over time

Valuation

What is Solid Biosciences stock price valuation
P/E
N/A
P/B
2.11
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS rose by 32% year-on-year and by 2.1% since the previous quarter
The price to book (P/B) is 96% more than the 5-year quarterly average of 1.2 and 2.2% more than the last 4 quarters average of 2.3
The equity is up by 45% year-on-year

Efficiency

How efficient is Solid Biosciences business performance
The return on assets has declined by 5% year-on-year
The ROIC is up by 5% QoQ
Solid Biosciences's return on equity has increased by 3% QoQ

Dividends

What is SLDB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SLDB.

Financial health

How did Solid Biosciences financials performed over time
Solid Biosciences's current ratio has increased by 48% YoY and by 5% QoQ
SLDB's quick ratio is up by 47% year-on-year and by 5% since the previous quarter
The debt is 95% lower than the equity
The equity is up by 45% year-on-year
The debt to equity has contracted by 44% YoY and by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.